Nature communications publishes pivotal data demonstrating efficacy and tolerability of csl and arcturus therapeutics' covid-19 vaccine

Data follow the approval of the world's first self-amplifying (sa-mrna) covid-19 vaccine for adults in japan.  these results add to recently published data on arct-154 demonstrating superior immunogenicity to omicron ba 4/5 compared to conventional mrna covid-19 vaccine booster and follow-up data demonstrating longer duration of immunity compared to traditional covid-19 mrna vaccine booster.
ARCT Ratings Summary
ARCT Quant Ranking